Clinical and Preclinical Pharmacokinetics and Pharmacodynamics of Mipomersen (Kynamro®): A Second-Generation Antisense Oligonucleotide Inhibitor of Apolipoprotein B
Crossref DOI link: https://doi.org/10.1007/s40262-014-0224-4
Published Online: 2015-01-06
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Geary, Richard S.
Baker, Brenda F.
Crooke, Stanley T.
License valid from 2015-01-06